Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14

Biochemical and Biophysical Research Communications

Volumn 409, Issue 1, 2011, Pages 58-63

  Park, Jun Hyoung ^a   Park, Sung Min ^a   Park, Ki Hoon ^b   Cho, Kyung Hyun ^b   Lee, Seung Taek ^a  

^a Yonsei University   (South Korea)

^b Yeungnam University   (South Korea)

Author keywords

Apolipoprotein A I; Cleavage site; Lipid metabolism; Matrix metalloproteinase; Substrate

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE 14; STROMELYSIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; ISOTOPE LABELING; LIPID METABOLISM; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LIPID INTERACTION; PROTEOMICS;

APOLIPOPROTEIN A-I; BLOOD PROTEINS; HUMANS; MATRIX METALLOPROTEINASE 14; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUBSTRATE SPECIFICITY;

EID: 79956213354     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.105     Document Type: Article

References (33)

1. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
2. Brew K., Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta 2010, 1803:55-71.
3. Nelson A.R., Fingleton B., Rothenberg M.L., Matrisian L.M. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 2000, 18:1135-1149.
4. Hwang I.K., Park S.-M., Kim S.Y., Lee S.-T. A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. Biochim. Biophys. Acta 2004, 1702:79-87.
5. Sung J.Y., Park S.-M., Lee C.H., Um J.W., Lee H.J., Kim J., Oh Y.J., Lee S.-T., Paik S.R., Chung K.C. Proteolytic cleavage of extracellular secreted α-synuclein via matrix metalloproteinases. J. Biol. Chem. 2005, 280:25216-25224.
6. Kim S.Y., Park S.-M., Lee S.-T. Apolipoprotein C-II is a novel substrate for matrix metalloproteinases. Biochem. Biophys. Res. Commun. 2006, 339:47-54.
7. Park S.-M., Hwang I.K., Kim S.Y., Lee S.J., Park K.S., Lee S.-T. Characterization of plasma gelsolin as a substrate for matrix metalloproteinases. Proteomics 2006, 6:1192-1199.
8. Park J.H., Park S.-M., Park S.H., Cho K.-H., Lee S.-T. Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14. Proteomics 2008, 8:2926-2935.
9. Karathanasis S.K., Zannis V.I., Breslow J.L. Isolation and characterization of the human apolipoprotein A-I gene. Proc. Natl. Acad. Sci. USA 1983, 80:6147-6151.
10. Frank P.G., Marcel Y.L. Apolipoprotein A-I: structure-function relationships. J. Lipid. Res. 2000, 41:853-872.
11. Brewer H.B., Jr., Ronan R., Meng M., Bishop C. Isolation and characterization of apolipoproteins A-I, A-II, and A-IV. Methods Enzymol. 1986, 128:223-246.
12. Park K.H., Jang W., Kim K.Y., Kim J.R., Cho K.-H. Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence. Biochem. Biophys. Res. Commun. 2010, 392:295-300.
13. Park K.H., Shin D.G., Kim J.R., Cho K.-H. Senescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activity. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:600-610.
14. Koo H.M., Kim J.-H., Hwang I.K., Lee S.-J., Kim T.-H., Rhee K.-H., Lee S.-T. Refolding of the catalytic and hinge domains of human MT1-MMP expressed in Escherichia coli and its characterization. Mol. Cells 2002, 13:114-120.
15. Lee S.-J., Yoo H.J., Bae Y.S., Kim H.-J., Lee S.-T. TIMP-1 inhibits apoptosis in breast carcinoma cells via a pathway involving pertussis toxin-sensitive G protein and c-Src. Biochem. Biophys. Res. Commun. 2003, 312:1196-1201.
16. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J. Biol. Chem. 1987, 262:10035-10038.
17. Matz C.E., Jonas A. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 1982, 257:4535-4540.
18. Cho K.-H., Durbin D.M., Jonas A. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. J. Lipid. Res. 2001, 42:379-389.
19. Lindstedt L., Saarinen J., Kalkkinen N., Welgus H., Kovanen P.T. Matrix metalloproteinases-3, -7, and -12, but not -9, reduce high density lipoprotein-induced cholesterol efflux from human macrophage foam cells by truncation of the carboxyl terminus of apolipoprotein A-I. Parallel losses of pre-beta particles and the high affinity component of efflux. J. Biol. Chem. 1999, 274:22627-22634.
20. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Genest J., Jr., Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 1999, 22:336-345.
21. Lee J.Y., Parks J.S. ATP-binding cassette transporter AI and its role in HDL formation. Curr. Opin. Lipidol. 2005, 16:19-25.
22. Davidson W.S., Thompson T.B. The structure of apolipoprotein A-I in high density lipoproteins. J. Biol. Chem. 2007, 282:22249-22253.
23. Thomas M.J., Bhat S., Sorci-Thomas M.G. Three-dimensional models of HDL apoA-I: implications for its assembly and function. J. Lipid. Res. 2008, 49:1875-1883.
24. Cho K.-H. Biomedicinal implications of high-density lipoprotein: its composition, structure, functions, and clinical applications. BMB Rep. 2009, 42:393-400.
25. Ajees A.A., Anantharamaiah G.M., Mishra V.K., Hussain M.M., Murthy H.M. Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc. Natl. Acad. Sci. USA 2006, 103:2126-2131.
26. Allan C.M., Fidge N.H., Morrison J.R., Kanellos J. Monoclonal antibodies to human apolipoprotein AI: probing the putative receptor binding domain of apolipoprotein AI. Biochem. J. 1993, 290(Pt 2):449-455.
27. Segrest J.P., Li L., Anantharamaiah G.M., Harvey S.C., Liadaki K.N., Zannis V. Structure and function of apolipoprotein A-I and high-density lipoprotein. Curr. Opin. Lipidol. 2000, 11:105-115.
28. Marcel Y.L., Kiss R.S. Structure-function relationships of apolipoprotein A-I: a flexible protein with dynamic lipid associations. Curr. Opin. Lipidol. 2003, 14:151-157.
29. Rajavashisth T.B., Liao J.K., Galis Z.S., Tripathi S., Laufs U., Tripathi J., Chai N.N., Xu X.P., Jovinge S., Shah P.K., Libby P. Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J. Biol. Chem. 1999, 274:11924-11929.
30. Rajavashisth T.B., Xu X.P., Jovinge S., Meisel S., Xu X.O., Chai N.N., Fishbein M.C., Kaul S., Cercek B., Sharifi B., Shah P.K. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 1999, 99:3103-3109.
31. Ray B.K., Shakya A., Turk J.R., Apte S.S., Ray A. Induction of the MMP-14 gene in macrophages of the atherosclerotic plaque: role of SAF-1 in the induction process. Circ. Res. 2004, 95:1082-1090.
32. Levine D.M., Parker T.S., Donnelly T.M., Walsh A., Rubin A.L. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA 1993, 90:12040-12044.
33. Mackness M.I., Abbott C., Arrol S., Durrington P.N. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 1993, 294:829-834.